Products like Ozempic and Wegovy, which contain semaglutide, have faced significant shortages, leading to approximately 11.1% of patients switching between different GLP-1 therapies within their first year of treatment
Convenience is the absolute primary driver and systemic effects are a secondary, or even non-existent, concern
Wegovy: The Weight Loss Distinction Despite sharing semaglutide as an active ingredient, Ozempic remains specifically for type 2 diabetes, whereas Wegovy and others are tailored for weight loss management
For context, bariatric surgery typically results in 2530% weight loss, making retatrutide potentially competitive with surgical outcomesbut without the scalpel
MK-677 amplifies both the frequency and amplitude of these pulses without suppressing your endogenous hormonal axis
You stop following them, the weight comes back